Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
Adrian R Tramontana(Peter MacCallum Cancer Centre), Monica A. Slavin(Peter MacCallum Cancer Centre), Justin T. Denholm, Aeron C. Hurt(Peter Doherty Institute), Allen Cheng(Providence Portland Medical Center), Joseph Doyle(The Alfred Hospital), Leon J. Worth(The University of Melbourne), Janet M. Harper(The Royal Melbourne Hospital), Patricia E. Ferguson(Westmead Institute for Medical Research), Karin Thursky(Peter MacCallum Cancer Centre), Dominic E. Dwyer(The University of Sydney), Biju George(Westmead Hospital), Alistair Reid(St Vincent's Hospital Melbourne), John F. Seymour(The Royal Melbourne Hospital), Kirsty Buising(St Vincent's Hospital Melbourne), C. Orla Morrissey(Alfred Health), Bin Wang(Westmead Hospital), Simon J. Harrison(Peter MacCallum Cancer Centre), Paul D.R. Johnson(The Alfred Hospital), Katherine M. Langan(The Alfred Hospital)
Cited by 140
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k